Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Marlies Dorloechter - JPND Joint Transnational Calls


Published on

A presentation on JPND Joint Transnational Calls, delivered by Marlies Dorloechter, JPND Management Board Member, at the Month of the Brain confernce, May 14th, Brussels, 2013

  • Login to see the comments

  • Be the first to like this

Marlies Dorloechter - JPND Joint Transnational Calls

  1. 1. Advanced Origami of Joint TransnationalCalls – NEURON and JPNDPD Dr. Marlies DorlöchterPT-DLR14/05/2013
  2. 2. European programme level collaboration for thebenefit of brain researchERA-NET scheme (FP6, 2002):„…cooperation and coordination of … activities carried out at national orregional level in the Member States and Associated States through thenetworking … at national or regional level, and the mutual opening ofnational and regional research programmes.“Joint Programming (Council decision, 2008):„…structured and strategic process whereby Member States agree … oncommon visions and Strategic Research Agendas (SRA) to address majorsocietal challenges. …Member States commit to Joint ProgrammingInitiatives (JPIs) where they implement together joint Strategic ResearchAgendas.“
  3. 3. European programme level collaboration for thebenefit of brain researchNetwork of European funding for Neuroscience researchEU Joint Programme – Neurodegenerative Disease ResearchNEURON JPNDStartand first steps2003Specific Support Action,FP62009EU Council Decision, JointProgramming pilotThematic scope disease-relatedneuroscienceneurodegenerativediseasesPartners/countries 21/16 27Aims Develop and maintain atransnational cooperationand research fundingframeworkAlign and build uponnational researchprogrammes to increaseimpact and effectiveness ofresearch efforts
  4. 4. Challenges: past – present - futureAcquiring a critical mass of partners willing to networkGaining knowledge on diversity of national programmesBuilding trust and understandingOvercoming fragmentationThinking big
  5. 5. Critical mass of relevant partnersTraditional work situationBefore ERA-NET schemeresearchers - programme officersAfter ERA-NET schemeresearchers - programme officers Information lacking on „who does what“ in Europe Idea of cooperation spread in ministries and funding agencies
  6. 6. Critical mass of relevant partnersAlready existing bilateral collaboration between ministries in the area ofdisease-related neurosciences built basis for NEURONNEURON, 2003 – 20044 funding organisations4 countries
  7. 7. Critical mass of relevant partnersAlready existing bilateral collaboration between ministries in the area ofdisease-related neurosciences built basis for NEURONNEURON, 2003 – 20044 funding organisations4 countriesNEURON, 2007 – 201118 funding organisations13 countries
  8. 8. Critical mass of relevant partnersAlready existing bilateral collaboration between ministries in the area ofdisease-related neurosciences built basis for NEURONNEURON, 2003 – 20044 funding organisations4 countriesNEURON, 2007 – 201118 funding organisations13 countriesNEURON II, 2012 – 201521 funding organisations16 countries
  9. 9. Knowledge on diversityof European programmesPrinciples of funding0102030405060708090100FWFFNRSFWOIWTGACRETFISFFICSO-MOHINSERMHEAAKAMNiSWMRCDFGBBSRCANCS-MECTSRCFNRMOHMECCNRSForskGIFANRZonMwHertieVWBMBFISCIII-FISLZPKNAWpercent(top-down/bottom-up)top-downbottom-up617171929241414123Principle of subsidiarityOvercoming research deficienciesStrengthening national innovationImproving research structuresScientific excellenceyesno21212529121285428Psychiatric diseasesOther neurological diseasesCognitive and behaviouralneuroscienceBasic neuroscienceNeurodegenerative diseasesyesnoMain focus0102030405060708090100AKAFWFVWFNRSFWOIWTGACRISFKNAWBBSRCANRCNRSMNiSWMECMRCGIFForskFISRCHRBANCS-MECTMOHFNRHEALZPCSO-MOHHertieZonMwISCIII-FISBMBFpercentage(basic/clinicalresearch)clinical researchbasic researchFunding activities in the area of disease-related neurosciecence from 33 privateand public organisations in 20 European countriesR. Girgenrath, M. Dorlöchter, 2008‚top down‘ vs. ‚bottom up‘‚clinical‘ vs. ‚basic‘ research Funding ‚priorities‘Neurodeg. Dis.Priority selectionScientific excellenceResearch structuresNational innovationNational deficienciesSubsidiarity principleBasic neurosci.Behav. Neurosci.Neurol. diseasesPsych. diseases
  10. 10. Trust and Understanding„….promote trust-building among programme managers in similarscientific and technological areas“ (ERA-NET scheme, EC Commission)2007, Berlin,NEURON kickoffmeeting2012, Malaga,NEURON meeting Trust and mutual understanding („trust and fun“) are listed as important successfactors in ERA-NET evaluation report. Soft skills do matter…
  11. 11. Overcoming fragmentation: Joint activities -e.g. transnational calls for proposals Scientific basis: Developing a common research agenda inclose connection to science communityScientificAdvisoryBoardMappingWorkshopsOnline Consultations
  12. 12. Joint activities – calls for proposals Administrative basis: Consenting on procedures anddeveloping a best practice modelEligibilityPersonnelTravelConsumablesEquipmentOverhead AnimalsAd hocpanelplusremoteStudysectionExternal (Peer)ReviewRemote Ad hocpanelStudy sectionplus remoteOne-stageproposalselectionTwo-stageproposalselectionGrant recipientsUniversitiesUniversityhospitalsIndustryNon-universityresearchinstituteIndividualresearchersCross-boarderfundingFinancial model‚Mixed pot‘‚Realcommonpot‘‚Virtualcommonpot‘Legalframework
  13. 13. Implementation of thematically focussed joint calls forproposals:Number of proposals and involved research groupsNEURON: JPND:- Neurodegeneration, 2008, 10.3 M € - Biomarker harmonisation, 2011, 13.6 M €- Method development I, 2009, 9.8 M € - Risk factors, 2012, 19 M € committed- Mental Disorders I, 2010, 9.4 M € - Health care systems, 2012, 9.8 M € committed- Stroke, 2011, 9.7 M €- Method development II, 2012, 10.5 M €- Mental Disorders II, 2013, 11.1 M € committedBenefits and added value, PIs quoted:- flexible instrument- little beaurocracy- fast decision process- high quality evaluation- complex results only possible withinterdisciplinary and transnationalresearchJoint activities – calls for proposals0100200300400500600700800Neurodeg.MethodsMentaldis.StrokeMethodsMentaldis.proposalsresearch groupsFunded: 10-12 projects per call
  14. 14. Action Groups to determine transnational research needsand opportunities in specific scientific areas (LongitudinalCohort Studies, Animal and Cell Models, Assisted Living Technologies)Joint activities – othersAnnual young scientist award for excellent paper inneuroscienceAction Groups to promote engagement, commitment andpartnerships (e.g. industry, user and public involvement, EC)Dialogue with large international collaborations andsocieties (e.g. “Ambient Assisted Living, AAL”, “Roadmap to Mental Health,ROAMER”, “European Brain Council, EBC”, “Federation of Neuroscience Societies,FENS”)
  15. 15. Thinking big – the futureBig questionsstrategic and political challengesIs programme-level collaboration sustainable? Most ERA-NETs without EC funding shrink (financial, legalhurdles), basic funding necessary through fees or EC contributionHow ‘reliable’ are national strategies? Changes in national strategies (e.g. after elections) affectcommitmentDoes the financial crisis affect collaboration? In kind contributions and financial commitment to joint calls andother joint activities decrease with national budget cuts
  16. 16. Thinking big – the futureBig goalsContinuing collaboration at programme level Maintain high added value through networkingStrengthenig research into brain functioning and diseases Raise awareness of extremely high burden of disease, societal challengeDeveloping national programmes Increase coordinated investment: national and ECAligning programmes: national and EC Create and maintain good balance between uniformity and diversityActing globally Include partners beyond EU (Canada, USA, China already participating orcontacted)
  17. 17. Thank you for your attention!Visit the JPND website:http://www.jpnd.euhttp://www.neurodegenerationresearch.euImage!/image/2192589095.jpg_genVisit the NEURON website: